FDA grants orphan drug status to Cullinan’s CLN-049 for AML

FDA grants orphan drug status to Cullinan’s CLN-049 for AML

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.